Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01557855 · ClinicalTrials.gov registry record
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
A clinical trial, sponsored by CardioDx.
- Completed
- Registry status
- 342
- Enrollment target
NCT01557855 is a clinical trial that has completed, run by CardioDx. The registered enrollment target is 342 participants.
The verdict
NCT01557855 has completed, sponsored by CardioDx.
- COMPLETED
- Registry status
- 342 participants
- Enrollment target
Study Summary
The objective of this study is to collect data on the commercial use of Corus CAD (Age/Sex/Gene Expression score - ASGES) blood test to evaluate the clinical referral patterns of Primary Care Physicians after receipt of their patients' Corus Score, and to better understand patient management patterns for clinicians ordering the test.
Interventions
- DIAGNOSTIC_TEST Corus CAD (ASGES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 342 participants |
| Start Date | 2012-04 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01557855
The ClinicalTrials.gov registry entry for NCT01557855 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 342 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CardioDx, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Corus CAD (ASGES) is the first listed.
NCT01557855 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01557855 about?
NCT01557855 is a clinical study titled "Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease". The objective of this study is to collect data on the commercial use of Corus CAD (Age/Sex/Gene Expression score - ASGES) blood test to evaluate the clinical referral patterns of Primary Care Physicians after receipt of their patients' Corus Score, and to better understand patient management pattern...
What is the current status of trial NCT01557855?
This trial is currently completed. The enrollment target is 342 participants. The study started on 2012-04. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01557855?
The interventions under investigation include: Corus CAD (ASGES) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01557855?
This trial is sponsored by CardioDx, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.